{"ref-id":"L12648","title":"FDA Approved Drug Products: Avastin (bevacizumab) injection","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125085s331lbl.pdf","parent_key":"DB00112"}
{"ref-id":"L12699","title":"ClinicalTrials.gov: Bevacizumab in Severe or Critical Patients with COVID-19 Pneumonia (BEST-CP)","url":"https://clinicaltrials.gov/ct2/show/NCT04275414","parent_key":"DB00112"}
{"ref-id":"L852","title":"American Association for the Study of Liver Diseases; Infectious Diseases Society of America. HCV guidance. http://hcvguidelines.org. Accessed June 12, 2017.","url":"http://hcvguidelines.org/full-report-view","parent_key":"DB00503"}
{"ref-id":"L3513","title":"FDA Approved Drug Products: NORVIR (ritonavir) Capsules, Soft Gelatin for Oral use","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020945s033lbl.pdf","parent_key":"DB00503"}
{"ref-id":"L12357","title":"FDA Approved Drug Products: Norvir (ritonavir) for oral use","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020659s071,%20209512s006,%20022417s023lbl.pdf","parent_key":"DB00503"}
{"ref-id":"L12363","title":"CaymanChem: Ritonavir MSDS","url":"https://www.caymanchem.com/msdss/13872m.pdf","parent_key":"DB00503"}
{"ref-id":"L12051","title":"FDA Approved Drug Products: Chloroquine Phosphate Oral Tablets","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/083082s050lbl.pdf","parent_key":"DB00608"}
{"ref-id":"L12054","title":"FDA Approved Drug Products: Aralen Chloroquine Oral Tablets (Discontinued)","url":"https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006002","parent_key":"DB00608"}
{"ref-id":"L14312","title":"FDA: Emergency use Authorization for Hydroxychloroquine and Chloroquine Revoked","url":"https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-chloroquine-and","parent_key":"DB00608"}
{"ref-id":"L10785","title":"FDA Approved Drug Products: Medrol Methylprednisolone Oral Tablets","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/011153s075lbl.pdf","parent_key":"DB00959"}
{"ref-id":"L10788","title":"FDA Approved Drug Products: Depo-Medrol Methylprednisolone Acetate Injection","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/011757s114lbl.pdf","parent_key":"DB00959"}
{"ref-id":"L10824","title":"Cayman Chemicals: Methylprednisolone MSDS","url":"https://www.caymanchem.com/msdss/15013m.pdf","parent_key":"DB00959"}
{"ref-id":"L12666","title":"Efficacy and Safety of Corticosteroids in COVID-19","url":"https://clinicaltrials.gov/ct2/show/NCT04273321","parent_key":"DB00959"}
{"ref-id":"L4614","title":"Current issues in pharmacy and medical sciences","url":"https://www.degruyter.com/downloadpdf/j/cipms.2014.27.issue-1/cipms-2014-0003/cipms-2014-0003.pdf","parent_key":"DB01050"}
{"ref-id":"L10695","title":"FDA Approved Drug Products: Decadron Dexamethasone Oral Tablet (Discontinued)","url":"https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011664","parent_key":"DB01234"}
{"ref-id":"L10698","title":"FDA Approved Drug Products: Ciprodex Dexamethasone and Ciprofloxacin Otic Suspension","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021537s017lbl.pdf","parent_key":"DB01234"}
{"ref-id":"L10701","title":"FDA Approved Drug Products: Dexamethasone Injection","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/40572s002lbledt.pdf","parent_key":"DB01234"}
{"ref-id":"L10704","title":"FDA Approved Drug Products: Dextenza Dexamethasone Ophthalmic Insert","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208742s001lbl.pdf","parent_key":"DB01234"}
{"ref-id":"L10707","title":"FDA Approved Drug Products: Dexycu Dexamethasone Intraocular Suspension","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208912s000lbl.pdf","parent_key":"DB01234"}
{"ref-id":"L10710","title":"FDA Approved Drug Products: Hemady Dexamethasone Oral Tablets","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211379s000lbl.pdf","parent_key":"DB01234"}
{"ref-id":"L10713","title":"FDA Approved Drug Products: Maxidex Dexamethasone Ophthalmic Suspension","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/013422s045lbl.pdf","parent_key":"DB01234"}
{"ref-id":"L10716","title":"FDA Approved Drug Products: Maxitrol Neomycin, Polymyxin B, and Dexamethasone Ophthalmic Suspension","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050023s036lbl.pdf","parent_key":"DB01234"}
{"ref-id":"L10719","title":"FDA Approved Drug Products: Ozurdex Dexamethasone Intravitreal Implant","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022315s012lbl.pdf","parent_key":"DB01234"}
{"ref-id":"L10722","title":"FDA Approved Drug Products: Maxitrol Neomycin, Polymyxin B, and Dexamethasone Ophthalmic Ointment","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050065s064lbl.pdf","parent_key":"DB01234"}
{"ref-id":"L10725","title":"FDA Approved Drug Products: Tobradex Tobramycin and Dexamethasone Ophthlamic Suspension","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/050818s001lbl.pdf","parent_key":"DB01234"}
{"ref-id":"L14318","title":"RECOVERY trial news release: dexamethasone","url":"https://www.recoverytrial.net/files/recovery_dexamethasone_statement_160620_v2final.pdf","parent_key":"DB01234"}
{"ref-id":"L14","title":"Link","url":"http://www.medilexicon.com/drugs/prezista.php","parent_key":"DB01264"}
{"ref-id":"L9227","title":"FDA Approved Drug Products: Prezista (darunavir) oral tablets/suspension","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021976s056,202895s027lbl.pdf","parent_key":"DB01264"}
{"ref-id":"L11988","title":"Medicines UK: Zentiva 800mg film coated tablets","url":"https://www.medicines.org.uk/emc/product/10124/smpc","parent_key":"DB01264"}
{"ref-id":"L12066","title":"Clinicaltrials.gov: Efficacy and Safety of Darunavir and Cobicistat for Treatment of Pneumonia Caused by 2019-nCoV (DACO-nCoV)","url":"https://clinicaltrials.gov/ct2/show/NCT04252274","parent_key":"DB01264"}
{"ref-id":"L8138","title":"Colchicine FDA label","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022352s017lbl.pdf","parent_key":"DB01394"}
{"ref-id":"L8141","title":"Colchicine: Up to Date","url":"https://www.uptodate.com/contents/management-of-familial-mediterranean-fever","parent_key":"DB01394"}
{"ref-id":"L8189","title":"Cayman chem MSDS","url":"https://www.caymanchem.com/msdss/9000760m.pdf","parent_key":"DB01394"}
{"ref-id":"L8192","title":"Pharmacology review, FDA","url":"https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/204820Orig1s000PharmR.pdf","parent_key":"DB01394"}
{"ref-id":"L12291","title":"Medline NIH: Colchicine","url":"https://medlineplus.gov/druginfo/meds/a682711.html","parent_key":"DB01394"}
{"ref-id":"L11163","title":"FDA Approved Drug Products: Kaletra (lopinavir/ritonavir) for oral use","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021251s058,021906s053lbl.pdf","parent_key":"DB01601"}
{"ref-id":"L12012","title":"Nature Biotechnology: Coronavirus puts drug repurposing on the fast track","url":"https://www.nature.com/articles/d41587-020-00003-1","parent_key":"DB01601"}
{"ref-id":"L12060","title":"CaymanChem: Lopinavir MSDS","url":"https://www.caymanchem.com/msdss/13854m.pdf","parent_key":"DB01601"}
{"ref-id":"L12063","title":"Health Canada Product Monograph: Kaletra (lopinavir/ritonavir) for oral use","url":"https://pdf.hres.ca/dpd_pm/00053305.PDF","parent_key":"DB01601"}
{"ref-id":"L12684","title":"CytoDyn: Treatment with CytoDyn's Leronlimab Indicates Significant Trend Toward Immunological Restoration in Severely Ill COVID-19 Patients","url":"https://www.cytodyn.com/newsroom/press-releases/detail/405/treatment-with-cytodyns-leronlimab-indicates-significant","parent_key":"DB05941"}
{"ref-id":"L12789","title":"FDA Approved Drug Products: Actemra Tocilizumab Intravenous or Subcutaneous Injection","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125276s127,125472s040lbl.pdf","parent_key":"DB06273"}
{"ref-id":"L12837","title":"Clinical Trials: TOCIVID-19","url":"https://clinicaltrials.gov/ct2/show/study/NCT04317092","parent_key":"DB06273"}
{"ref-id":"L12843","title":"Clinical Trials: COVACTA","url":"https://clinicaltrials.gov/ct2/show/NCT04320615","parent_key":"DB06273"}
{"ref-id":"L12651","title":"FDA Approved Products: Gilenya (fingolimod) oral capsules","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022527s031lbl.pdf","parent_key":"DB08868"}
{"ref-id":"L12654","title":"Clinicaltrials.gov: Fingolimod in COVID-19","url":"https://clinicaltrials.gov/ct2/show/NCT04280588","parent_key":"DB08868"}
{"ref-id":"L12657","title":"Clinical trials on drug repositioning for COVID-19 treatment","url":"https://www.paho.org/journal/sites/default/files/2020-03/40-20-249-Rosa-prelim.pdf?ua=1","parent_key":"DB08868"}
{"ref-id":"L12690","title":"European Medicines Agency Public Assessment Report: Gilenya (fingolimod)","url":"https://www.ema.europa.eu/en/documents/assessment-report/gilenya-epar-public-assessment-report_en.pdf","parent_key":"DB08868"}
{"ref-id":"L852","title":"American Association for the Study of Liver Diseases; Infectious Diseases Society of America. HCV guidance. http://hcvguidelines.org. Accessed June 12, 2017.","url":"http://hcvguidelines.org/full-report-view","parent_key":"DB11574"}
{"ref-id":"L10253","title":"Zepatier FDA label","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208261s002lbl.pdf","parent_key":"DB11574"}
{"ref-id":"L12039","title":"Coronavirus treatment: Vaccines/drugs in the pipeline for Covid-19","url":"https://www.clinicaltrialsarena.com/analysis/coronavirus-mers-cov-drugs/","parent_key":"DB11676"}
{"ref-id":"L12042","title":"BioCryst Initiates Phase 1 Clinical Trial of Galidesivir","url":"http://ir.biocryst.com/news-releases/news-release-details/biocryst-initiates-phase-1-clinical-trial-galidesivir","parent_key":"DB11676"}
{"ref-id":"L12084","title":"Galidesivir - BioCryst","url":"https://www.biocryst.com/our-program/galidesivir/","parent_key":"DB11676"}
{"ref-id":"L12012","title":"Nature Biotechnology: Coronavirus puts drug repurposing on the fast track","url":"https://www.nature.com/articles/d41587-020-00003-1","parent_key":"DB12466"}
{"ref-id":"L12075","title":"Pharmaceuticals and Medical Devices Agency: Avigan (favipiravir) Review Report","url":"https://www.pmda.go.jp/files/000210319.pdf","parent_key":"DB12466"}
{"ref-id":"L12090","title":"World Health Organization: Influenza (Avian and other zoonotic)","url":"https://www.who.int/news-room/fact-sheets/detail/influenza-(avian-and-other-zoonotic)","parent_key":"DB12466"}
{"ref-id":"L13874","title":"NIH: Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection (NCT04374032)","url":"https://clinicaltrials.gov/ct2/show/NCT04374032","parent_key":"DB12668"}
{"ref-id":"L13877","title":"Bosna Lijek: Enkorten Metenkefalin and Tridecactide Injection","url":"http://www.bosnalijek.com/products-L2e?c=ign&ign=metenkefalin%20%2B%20tridecactide","parent_key":"DB12668"}
{"ref-id":"L13889","title":"Bosna Lijek: Enkorten Summary of Product Characteristics","url":"http://bosnalijek.ba/enkorten-liofilizat-za-otopinu-za-injekciju-6-bocica-liofilizata---6-ampula-otopine-za-rastvaranje-5-mg---1-mg-","parent_key":"DB12668"}
{"ref-id":"L12012","title":"Nature Biotechnology: Coronavirus puts drug repurposing on the fast track","url":"https://www.nature.com/articles/d41587-020-00003-1","parent_key":"DB13609"}
{"ref-id":"L12174","title":"NIH: Clinical Trial NCT04252664","url":"https://clinicaltrials.gov/ct2/show/NCT04252664","parent_key":"DB14761"}
{"ref-id":"L12177","title":"NIH: Clinical Trial NCT04257656","url":"https://clinicaltrials.gov/ct2/show/NCT04257656","parent_key":"DB14761"}
{"ref-id":"L13236","title":"FDA: Emergency Use Authorization For Remdesivir","url":"https://www.fda.gov/media/137564/download","parent_key":"DB14761"}
{"ref-id":"L12609","title":"FDA: Emergency Use Authorization Information","url":"https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization","parent_key":"DB14761"}
{"ref-id":"L13239","title":"FDA: Fact Sheet For Health Care Providers EUA of Remdesivir","url":"https://www.fda.gov/media/137566/download","parent_key":"DB14761"}
{"ref-id":"L12078","title":"World Health Organization: Landscape analysis of therapeutics as of February 17 2020","url":"https://www.who.int/blueprint/priority-diseases/key-action/Table_of_therapeutics_Appendix_17022020.pdf?ua=1","parent_key":"DB14999"}
{"ref-id":"L12081","title":"FDA approved products: Extravia (interferon beta-1b) subcutaneous injection","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125290s067lbl.pdf","parent_key":"DB14999"}
{"ref-id":"L12012","title":"Nature Biotechnology: Coronavirus puts drug repurposing on the fast track","url":"https://www.nature.com/articles/d41587-020-00003-1","parent_key":"DB14999"}
{"ref-id":"L12093","title":"Product monograph: Avonex pen (interferon beta 1a)","url":"https://www.wellrx.com/avonex%20pen/monographs/","parent_key":"DB14999"}
{"ref-id":"L12096","title":"FDA approved products: Betaseron (interferon beta 1b) subcutaneous injection","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103471s5193lbl.pdf","parent_key":"DB14999"}
{"ref-id":"L12105","title":"EMD Serono MSDS: Interferon beta 1a","url":"https://imgcdn.mckesson.com/CumulusWeb/Click_and_learn/MSDS_9SERO_REBIF_SYR_%2044MCG.pdf","parent_key":"DB14999"}
{"ref-id":"L12111","title":"ThPDB: Interferon beta1a","url":"http://crdd.osdd.net/raghava/thpdb/display_thppid_sub.php?details=Th1049","parent_key":"DB14999"}
{"ref-id":"L12120","title":"DailyMed: Avonex (interferon beta1a) solution for injection","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d70a39cc-de15-4c12-a1ec-8063b69ea0e1","parent_key":"DB14999"}
{"ref-id":"L12087","title":"RT Question More: China tests Russian anti-viral drug which might treat coronavirus as Moscow warns of possible 'mass outbreak'","url":"https://www.rt.com/russia/480037-china-tests-russian-drug-coronavirus/","parent_key":"DB15622"}
{"ref-id":"L12165","title":"Triazavirin","url":"http://www.triazavirin.ru","parent_key":"DB15622"}
{"ref-id":"L12045","title":"NIH AIDSinfo: TMC-310911 Pharmacology","url":"https://aidsinfo.nih.gov/drugs/549/tmc-310911/0/professional","parent_key":"DB15623"}
{"ref-id":"L12012","title":"Nature Biotechnology: Coronavirus puts drug repurposing on the fast track","url":"https://www.nature.com/articles/d41587-020-00003-1","parent_key":"DB15623"}
{"ref-id":"L12645","title":"Pharmaceutical Business Review: Moderna's mRNA-1273 vaccine","url":"https://www.pharmaceutical-business-review.com/news/moderna-mrna-1273-coronavirus-trial/","parent_key":"DB15654"}
{"ref-id":"L12660","title":"Clinical Trials: Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis SARS CoV-2 Infection","url":"https://clinicaltrials.gov/ct2/show/NCT04283461","parent_key":"DB15654"}
{"ref-id":"L12675","title":"Chinese Clinical Trial Register: A phase I clinical trial for recombinant novel coronavirus (2019-COV) vaccine (adenoviral vector)","url":"http://www.chictr.org.cn/showprojen.aspx?proj=51154","parent_key":"DB15655"}
{"ref-id":"L12678","title":"Antibody Society: COVID-19 Archives","url":"https://www.antibodysociety.org/covid-19/","parent_key":"DB15655"}
{"ref-id":"L12669","title":"Clinical Trials: A Study of a Candidate COVID-19 Vaccine (COV001)","url":"https://www.clinicaltrials.gov/ct2/show/NCT04324606","parent_key":"DB15656"}
{"ref-id":"L12672","title":"TrialSite News: University of Oxford Commences Clinical Trial for Vaccine Candidate (ChAdOx1 nCoV-19) Targeting COVID-19","url":"https://www.trialsitenews.com/university-of-oxford-commences-clinical-trial-for-vaccine-candidate-chadox1-ncov-19-targeting-covid-19-2/","parent_key":"DB15656"}
{"ref-id":"L12717","title":"DC Chemicals: EIDD-2081 MSDS","url":"http://www.dcchemicals.com/usr/uploads/gene/2020326/MSDS_12096_DC27035_2349386-89-4.pdf","parent_key":"DB15661"}
{"ref-id":"L13239","title":"FDA: Fact Sheet For Health Care Providers EUA of Remdesivir","url":"https://www.fda.gov/media/137566/download","parent_key":"DB15686"}
{"ref-id":"L13775","title":"European Patent Specification: 1'-substituted carba-nucleoside analogs for antiviral treatment","url":"https://patentimages.storage.googleapis.com/4b/84/70/16d3c8634171ba/EP2937350B1.pdf","parent_key":"DB15686"}
{"ref-id":"L13874","title":"NIH: Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection (NCT04374032)","url":"https://clinicaltrials.gov/ct2/show/NCT04374032","parent_key":"DB15687"}
{"ref-id":"L13877","title":"Bosna Lijek: Enkorten Metenkefalin and Tridecactide Injection","url":"http://www.bosnalijek.com/products-L2e?c=ign&ign=metenkefalin%20%2B%20tridecactide","parent_key":"DB15687"}
{"ref-id":"L13868","title":"NIH: Safety and Efficacy Trial of Vazegepant Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen (NCT04346615)","url":"https://clinicaltrials.gov/ct2/show/NCT04346615","parent_key":"DB15688"}
{"ref-id":"L13886","title":"Practical Neurology: Vazegepant, Investigational Drug Being Studied for Migraine, to Enter Phase 2 Trial for COVID-19 Treatment","url":"https://practicalneurology.com/news/vazegepant-investigational-drug-being-studied-for-migraine-to-enter-phase-2-trial-for-covid-19-treatment","parent_key":"DB15688"}
{"ref-id":"L14303","title":"Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19","url":"https://clinicaltrials.gov/ct2/show/NCT04426695?term=REGN10933&draw=2&rank=2","parent_key":"DB15691"}
{"ref-id":"L14306","title":"Regeneron: Regeneron begins first clinical trials of antibody-antiviral cocktail REGN-COV-2 for the treatment and prevention of COVID-19","url":"https://investor.regeneron.com/news-releases/news-release-details/regeneron-begins-first-clinical-trials-anti-viral-antibody","parent_key":"DB15691"}
{"ref-id":"L14333","title":"FDA recommendations for investigational COVID-19 convalescent plasma","url":"https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/recommendations-investigational-covid-19-convalescent-plasma","parent_key":"DB15692"}
{"ref-id":"L14372","title":"INO-4800 Phase I clinical trial NCT04336410","url":"https://clinicaltrials.gov/ct2/show/NCT04336410","parent_key":"DB15693"}
{"ref-id":"L14375","title":"INOVIO Press release phase 1/2 clinical trial","url":"http://ir.inovio.com/news-releases/news-releases-details/2020/INOVIO-and-IVI-Partner-with-Seoul-National-University-Hospital-to-Start-Phase-12-Clinical-Trial-of-INOVIOs-COVID-19-DNA-Vaccine-INO-4800-in-South-Korea/default.aspx","parent_key":"DB15693"}